Detail akcie Adiuvo Invest online

Business Summary: Adiuvo Investments SA is a Poland-based company engaged in the financial industry. The Company focuses on the selection, development, financing and commercialization of biomedical projects on the international market. By providing intellectual property protection, technology validation in clinical trials and obtaining certificates allowing products to market, Adiuvo Investments SA is able to commercialize projects in diverse business model and internationally. The Company is looking for and invests in projects in the segments of the nutraceutical, medical devices and the digital health. Its business portfolio encompasses Airway Medix, Algae Labs, Carocelle, Cambridge Chocolate Technology, Endomedical, Esthechoc, Glia, Joint Polish Investment Fund, Marmar Investment, Nanoxide and Peptaderm.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Adiuvo Investments SA revenues increased from PLN449K to PLN990K. Net loss applicable to common stockholders excluding extraordinary items decreased 82% to PLN10.1M. Revenues reflect Poland (Country) segment increase from PLN449K to PLN1M. Lower net loss reflects Medical Equipment segment loss decrease of 88% to PLN4.6M, Nutraceutical Platform segment income totaling PLN8.5M vs. loss of PLN3.4M.